Letter to the Editor: Pre‐Treatment Liver Stiffness Is a Stronger Predictor of Hepatocellular Carcinoma Development Than Post‐Treatment Liver Stiffness After Hepatitis C Virus Eradication

Documenti analoghi

• Response to “Letter to the Editor: Pre‐Treatment Liver Stiffness is a Stronger Predictor of Hepatocellular Carcinoma Development Than Post‐Treatment Liver Stiffness After Hepatitis C Virus Eradication”
  di: Takuma Nakatsuka, et al.
  Pubblicazione: (2025)
• Letter to the Editor: “Effect of Direct‐Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japan”
  di: Haigu Ke, et al.
  Pubblicazione: (2026)
• Letter to the Editor: “Excessive Visceral Adipose Tissue Accumulation Increases the Risk of Recurrence and Mortality After Curative Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Associated Hepatocellular Carcinoma”
  di: Lixia Yao, et al.
  Pubblicazione: (2025)
• Effect of Direct‐Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japan
  di: Hironori Ochi, et al.
  Pubblicazione: (2026)
• Letter to the Editor Regarding “Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C”
  di: Tiancheng Gong
  Pubblicazione: (2025)